Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

Effects of spleen status on early outcomes after hematopoietic cell transplantation.

Akpek G, Pasquini MC, Logan B, Agovi MA, Lazarus HM, Marks DI, Bornhaeüser M, Ringdén O, Maziarz RT, Gupta V, Popat U, Maharaj D, Bolwell BJ, Rizzo JD, Ballen KK, Cooke KR, McCarthy PL, Ho VT.

Bone Marrow Transplant. 2013 Jun;48(6):825-31. doi: 10.1038/bmt.2012.249. Epub 2012 Dec 10.

2.

Impact of donor age on outcome after allogeneic hematopoietic cell transplantation.

Rezvani AR, Storer BE, Guthrie KA, Schoch HG, Maloney DG, Sandmaier BM, Storb R.

Biol Blood Marrow Transplant. 2015 Jan;21(1):105-12. doi: 10.1016/j.bbmt.2014.09.021. Epub 2014 Sep 30.

3.

Absolute lymphocyte count recovery after allogeneic hematopoietic stem cell transplantation predicts clinical outcome.

Kim HT, Armand P, Frederick D, Andler E, Cutler C, Koreth J, Alyea EP 3rd, Antin JH, Soiffer RJ, Ritz J, Ho VT.

Biol Blood Marrow Transplant. 2015 May;21(5):873-80. doi: 10.1016/j.bbmt.2015.01.019. Epub 2015 Jan 23.

4.

Similar survival following HLA-identical sibling transplantation for standard indication in children with haematologic malignancies: a single center comparison of mobilized peripheral blood stem cell with bone marrow transplantation.

Meisel R, Enczmann J, Balzer S, Bernbeck B, Kramm C, Schönberger S, Sinha K, Tröger A, Wernet P, Göbel U, Laws HJ, Dilloo D.

Klin Padiatr. 2005 May-Jun;217(3):135-41.

PMID:
15858704
5.

Nonfluorodeoxyglucose-Avid Persistent Splenomegaly at Time of Transplantation Delays Neutrophil and Platelets Engraftment without Affecting Survival in Patients with Lymphomas Undergoing Allogeneic Hematopoietic Cell Transplantation.

Khimani F, Jeong DK, Miladinovic B, Nishihori T, Ayala E, Locke F, Mishra A, Chavez J, Shah B, Gage K, Kharfan-Dabaja MA.

Biol Blood Marrow Transplant. 2016 Dec;22(12):2201-2207. doi: 10.1016/j.bbmt.2016.09.014. Epub 2016 Sep 19.

6.

[Umbilical cord blood cell transplantation from an unrelated donor: dual transplantation].

Bautista G, Regidor C, Gonzalo-Daganzo R, Cabrera JR.

Methods Find Exp Clin Pharmacol. 2010 Dec;32 Suppl A:47-51. Spanish.

PMID:
21381288
7.

Effect of Total Nucleated and CD34(+) Cell Dose on Outcome after Allogeneic Hematopoietic Stem Cell Transplantation.

Remberger M, Törlén J, Ringdén O, Engström M, Watz E, Uhlin M, Mattsson J.

Biol Blood Marrow Transplant. 2015 May;21(5):889-93. doi: 10.1016/j.bbmt.2015.01.025. Epub 2015 Feb 4.

8.

CD34+ stem cell augmentation of elutriated allogeneic bone marrow grafts: results of a phase II clinical trial of engraftment and graft-versus-host disease prophylaxis in high-risk hematologic malignancies.

O'Donnell PV, Jones RJ, Vogelsang GB, Seber A, Ambinder RF, Flinn I, Miller C, Marcellus DC, Griffin C, Abrams R, Braine HG, Grever M, Hess AD, Piantadosi S, Noga SJ.

Bone Marrow Transplant. 1998 Nov;22(10):947-55.

9.

Recombinant human thrombopoietin promotes platelet engraftment after haploidentical hematopoietic stem cell transplantation: a prospective randomized controlled trial.

Han TT, Xu LP, Liu DH, Liu KY, Wang FR, Wang Y, Yan CH, Chen YH, Sun YQ, Ji Y, Wang JZ, Zhang XH, Huang XJ.

Ann Hematol. 2015 Jan;94(1):117-28. doi: 10.1007/s00277-014-2158-1. Epub 2014 Jul 30.

PMID:
25069650
10.

Single and multiple dose MultiStem (multipotent adult progenitor cell) therapy prophylaxis of acute graft-versus-host disease in myeloablative allogeneic hematopoietic cell transplantation: a phase 1 trial.

Maziarz RT, Devos T, Bachier CR, Goldstein SC, Leis JF, Devine SM, Meyers G, Gajewski JL, Maertens J, Deans RJ, Van't Hof W, Lazarus HM.

Biol Blood Marrow Transplant. 2015 Apr;21(4):720-8. doi: 10.1016/j.bbmt.2014.12.025. Epub 2014 Dec 30.

11.
12.

No impact of total or myeloid Cd34+ cell numbers on neutrophil engraftment and transplantation-related mortality after allogeneic pediatric bone marrow transplantation.

Pichler H, Witt V, Winter E, Boztug H, Glogova E, Pötschger U, Matthes-Martin S, Fritsch G.

Biol Blood Marrow Transplant. 2014 May;20(5):676-83. doi: 10.1016/j.bbmt.2014.01.026. Epub 2014 Jan 31.

13.

[Hematopoietic reconstitution on the prognosis of hematological malignancies after allogeneic hematopoietic stem cell transplantation].

Zhang Y, Ren HY, Qiu ZX, Wang MJ, Xu WL, Liu W, Li Y, Dong YJ, Yin Y, Sun YH, Wang LH, Ou JP, Wang WS, Cen XN.

Zhonghua Xue Ye Xue Za Zhi. 2012 Sep;33(9):747-50. doi: 10.3760/cma.j.issn.0253-2727.2012.09.013. Chinese.

PMID:
23336230
14.

Allogeneic peripheral blood stem cell transplantation in patients with early-phase hematologic malignancy: a retrospective comparison of short-term outcome with bone marrow transplantation.

Lemoli RM, Bandini G, Leopardi G, Rosti G, Bonini A, Fortuna A, Rondelli D, Mangianti S, Motta MR, Rizzi S, Tassi C, Cavo M, Remiddi C, Curti A, Conte R, Tura S.

Haematologica. 1998 Jan;83(1):48-55.

15.

Impact of postgrafting immunosuppressive regimens on nonrelapse mortality and survival after nonmyeloablative allogeneic hematopoietic stem cell transplant using the fludarabine and low-dose total-body irradiation 200-cGy.

Koh LP, Chen CS, Tai BC, Hwang WY, Tan LK, Ng HY, Linn YC, Koh MB, Goh YT, Tan B, Lim S, Lee YM, Tan KW, Liu TC, Ng HJ, Loh YS, Mow BM, Tan DC, Tan PH.

Biol Blood Marrow Transplant. 2007 Jul;13(7):790-805. Epub 2007 Apr 23.

16.

Immunosuppressive total lymphoid irradiation-based reconditioning regimens enable engraftment after graft rejection or graft failure in patients treated with allogeneic hematopoietic stem cell transplantation.

Heinzelmann F, Lang PJ, Ottinger H, Faul C, Bethge W, Handgretinger R, Bamberg M, Belka C.

Int J Radiat Oncol Biol Phys. 2008 Feb 1;70(2):523-8. Epub 2007 Sep 14.

PMID:
17869449
17.

A Two-Step Haploidentical Versus a Two-Step Matched Related Allogeneic Myeloablative Peripheral Blood Stem Cell Transplantation.

Gaballa S, Palmisiano N, Alpdogan O, Carabasi M, Filicko-O'Hara J, Kasner M, Kraft WK, Leiby B, Martinez-Outschoorn U, O'Hara W, Pro B, Rudolph S, Sharma M, Wagner JL, Weiss M, Flomenberg N, Grosso D.

Biol Blood Marrow Transplant. 2016 Jan;22(1):141-8. doi: 10.1016/j.bbmt.2015.09.017. Epub 2015 Sep 28.

18.

Factors predicting haematopoietic recovery in patients undergoing autologous transplantation: 11-year experience from a single centre.

Bai L, Xia W, Wong K, Reid C, Ward C, Greenwood M.

Ann Hematol. 2014 Oct;93(10):1655-64. doi: 10.1007/s00277-014-2112-2. Epub 2014 May 29.

PMID:
24870941
19.
20.

[CD34+ cell dose and hematologic recovery in allogeneic peripheral blood stem cell transplantation].

Sawada H, Wake A, Yamasaki Y, Izumi Y.

Rinsho Ketsueki. 2000 Jun;41(6):500-6. Japanese.

PMID:
10921350

Supplemental Content

Support Center